Cargando…

Anomalous altered expressions of downstream gene-targets in TP53-miRNA pathways in head and neck cancer

The prevalence of head and neck squamous cell carcinoma, HNSCC, continues to grow. Change in the expression of TP53 in HNSCC affects its downstream miRNAs and their gene targets, anomalously altering the expressions of the five genes, MEIS1, AGTR1, DTL, TYMS and BAK1. These expression alterations fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitra, Sanga, Mukherjee, Nupur, Das, Smarajit, Das, Pijush, Panda, Chinmay Kumar, Chakrabarti, Jayprokas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385823/ https://www.ncbi.nlm.nih.gov/pubmed/25186767 http://dx.doi.org/10.1038/srep06280

Ejemplares similares

p53 in head and neck cancer: Functional consequences and environmental implications of TP53 mutations
por: Peltonen, Jenni K, et al.
Publicado: (2010)

Hepatitis B virus X protein mediated suppression of miRNA-122 expression enhances hepatoblastoma cell proliferation through cyclin G1-p53 axis
por: Bandopadhyay, Manikankana, et al.
Publicado: (2016)

LIMD1 is more frequently altered than RB1 in head and neck squamous cell carcinoma: clinical and prognostic implications
por: Ghosh, Susmita, et al.
Publicado: (2010)

Integrative Analysis of TP53INP2 in Head and Neck Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2021)

TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection
por: Klinakis, Apostolos, et al.
Publicado: (2020)

lnCeDB: Database of Human Long Noncoding RNA Acting as Competing Endogenous RNA
por: Das, Shaoli, et al.
Publicado: (2014)

HumanViCe: host ceRNA network in virus infected cells in human
por: Ghosal, Suman, et al.
Publicado: (2014)

SeedSeq: Off-Target Transcriptome Database
por: Das, Shaoli, et al.
Publicado: (2013)

Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer
por: Lyu, Haoyu, et al.
Publicado: (2019)

The Prognostic Value of TP53 Alteration in Patients with Head and Neck Squamous Cell Carcinoma Receiving Immunotherapy
por: Jiang, Chao, et al.
Publicado: (2022)

Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients
por: Sacconi, Andrea, et al.
Publicado: (2023)

Overexpression of EGFR in Head and Neck Squamous Cell Carcinoma Is Associated with Inactivation of SH3GL2 and CDC25A Genes
por: Maiti, Guru Prasad, et al.
Publicado: (2013)

Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss
por: Gross, Andrew M, et al.
Publicado: (2014)

Nucleotide variants and protein expression of TP53 in a Sri Lankan cohort of patients with head and neck cancer
por: Manoharan, Vahinipriya, et al.
Publicado: (2019)

Associations among smoking, MGMT hypermethylation, TP53-mutations, and relapse in head and neck squamous cell carcinoma
por: Matsuda, Shinichi, et al.
Publicado: (2020)

A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma
por: Shi, Congyu, et al.
Publicado: (2021)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

Circ2Traits: a comprehensive database for circular RNA potentially associated with disease and traits
por: Ghosal, Suman, et al.
Publicado: (2013)

Competing Endogenous RNA: The Key to Posttranscriptional Regulation
por: Sen, Rituparno, et al.
Publicado: (2014)

Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer
por: van Ginkel, Joost H., et al.
Publicado: (2016)

Ricolinostat enhances adavosertib-induced mitotic catastrophe in TP53-mutated head and neck squamous cell carcinoma cells
por: Miyake, Keitaro, et al.
Publicado: (2022)

Exosomal microRNAs Targeting TP53 Gene as Promising Prognostic Markers for Head and Neck Squamous Cell Carcinoma
por: Jayaseelan, Vijayashree Priyadharsini, et al.
Publicado: (2022)

Dynamic changes in global microRNAome and transcriptome reveal complex miRNA-mRNA regulated host response to Japanese Encephalitis Virus in microglial cells
por: Kumari, Bharti, et al.
Publicado: (2016)

Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study
por: Peltonen, Jenni K, et al.
Publicado: (2011)

Homozygous deletions of UGT2B17 modifies effects of smoking on TP53-mutations and relapse of head and neck carcinoma
por: Mafune, Aki, et al.
Publicado: (2015)

TP53-Associated Ion Channel Genes Serve as Prognostic Predictor and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma
por: Sun, Jing, et al.
Publicado: (2020)

In Reply: TP53 Alteration Status and Tumor Mutational Burden Score: Prevalence and Prognosis in Head and Neck Squamous Cell Carcinoma
por: Burcher, Kimberly M, et al.
Publicado: (2022)

Mutated TP53 in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Carcinoma Patients
por: Kampel, Liyona, et al.
Publicado: (2023)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
por: Wang, Haiwei, et al.
Publicado: (2022)

TP53 regulates miRNA association with AGO2 to remodel the miRNA–mRNA interaction network
por: Krell, Jonathan, et al.
Publicado: (2016)

Optimisation of TP53 reporters by systematic dissection of synthetic TP53 response elements
por: Trauernicht, Max, et al.
Publicado: (2023)

Pattern of nucleotide variants of TP53 and their correlation with the expression of p53 and its downstream proteins in a Sri Lankan cohort of breast and colorectal cancer patients
por: Manoharan, Vahinipriya, et al.
Publicado: (2020)

The TP53 fertility network
por: Paskulin, Diego d’Avila, et al.
Publicado: (2012)

TP53: an oncogene in disguise
por: Soussi, T, et al.
Publicado: (2015)

TP53 in Myelodysplastic Syndromes
por: Jiang, Yan, et al.
Publicado: (2021)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer
por: Caponio, Vito Carlo Alberto, et al.
Publicado: (2020)

TP53 mutations in head and neck cancer cells determine the Warburg phenotypic switch creating metabolic vulnerabilities and therapeutic opportunities for stratified therapies
por: Wilkie, Mark D., et al.
Publicado: (2020)

Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
por: Sonkin, Dmitriy
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nr2crp726n7oslek8s4djg2e6r